Lung disease burden assessment by oscillometry in a systematically disadvantaged urban population experiencing homelessness or at-risk for homelessness in Ottawa, Canada from a prospective observational study

Smita Pakhale, Carly Visentin, Saania Tariq, Tina Kaur, Kelly Florence, Ted Bignell, Sadia Jama, Nina Huynh, Robert Boyd, Joanne Haddad, Gonzalo G Alvarez, Smita Pakhale, Carly Visentin, Saania Tariq, Tina Kaur, Kelly Florence, Ted Bignell, Sadia Jama, Nina Huynh, Robert Boyd, Joanne Haddad, Gonzalo G Alvarez

Abstract

Rationale: Oscillometry is an emerging technique that offers some advantages over spirometry as it does not require forced exhalation and may detect early changes in respiratory pathology. Obstructive lung disease disproportionately impacts people experiencing homelessness with a high symptoms burden, yet oscillometry is not studied in this population.

Objectives: To assess lung disease and symptom burden using oscillometry in people experiencing homelessness or at-risk of homelessness using a community-based participatory action research approach (The Bridge Model™).

Methods: Of 80 recruited, 55 completed baseline oscillometry, 64 completed spirometry, and all completed patient-reported outcomes with demographics, health, and respiratory symptom related questionnaires in the Participatory Research in Ottawa: Management and Point-of-Care for Tobacco Dependence project. Using a two-tail t-test, we compared mean oscillometry values for airway resistance (R5-20), reactance area under the curve (Ax) and reactance at 5 Hz (X5) amongst individuals with fixed-ratio method (FEV1/FVC ratio < 0.70) and LLN (FEV1/FVC ratio ≤ LLN) spirometry diagnosed chronic obstructive pulmonary disease (COPD). We compared mean oscillometry parameters based on participants' COPD assessment test (CAT) scores using ANOVA test.

Results: There was no significant difference between the pre- and post- bronchodilator values of R5-20 and Ax for the fixed ratio method (p = 0.63 and 0.43) and the LLN method (p = 0.45 and 0.36). There was a significant difference in all three of the oscillometry parameters, R5-20, Ax and X5, based on CAT score (p = 0.009, 0.007 and 0.05, respectively). There was a significant difference in R5-20 and Ax based on the presence of phlegm (p = 0.03 and 0.02, respectively) and the presence of wheeze (p = 0.05 and 0.01, respectively). Oscillometry data did not correlate with spirometry data, but it was associated with CAT scores and correlated with the presence of self-reported symptoms of phlegm and wheeze in this population.

Conclusions: Oscillometry is associated with respiratory symptom burden and highlights the need for future studies to generate more robust data regarding the use of oscillometry in systematically disadvantaged populations where disease burden is disproportionately higher than the general population.

Trial registration: ClinicalTrails.gov-NCT03626064, Retrospective registered: August 2018, https://ichgcp.net/clinical-trials-registry/NCT03626064.

Keywords: Asthma; COPD; Community-based research; Homelessness; Lung function; Patient engagement.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Mean R5–20, Ax and X5 values based on the COPD assessment test (CAT) score. Mean oscillometry values are reported for R5–20, Ax and X5 based on the CAT Score. R5–20 is a measure of small airway resistance. Ax is a measure of the area under the reactance curve. X5 is a measure of airway elastance. CAT score is classified as low (< 10), medium (10–20), high (21–30) and very high (> 30). p Values were generated using the ANOVA test. p Values for R5–20, Ax and X5 based on CAT score were 0.009, 0.007, and 0.05, respectively. Sample size based on CAT score group were as follows, low n = 10, medium n = 29, high n = 15, and very high n = 5

References

    1. Graham BL, Steenbruggen I, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, et al. Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200:e70–e88. doi: 10.1164/rccm.201908-1590ST.
    1. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi: 10.1183/09031936.05.00034805.
    1. Pakhale S, Bshouty Z, Marras TK. Comparison of per cent predicted and percentile values for pulmonary function test interpretation. Can Respir J. 2009;16:189–193. doi: 10.1155/2009/912185.
    1. Graham BL, Steenbruggen I, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, et al. Standardization of spirometry 2019 update an official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200:e70–e88. doi: 10.1164/rccm.201908-1590ST.
    1. McNulty W, Usmani OS. Techniques of assessing small airways dysfunction. Eur Clin Respir J. 2014.
    1. Dubois AB, Brody AW, Lewis DH, Burgess BF. Oscillation mechanics of lungs and chest in man. J Appl Physiol. 1956;8:587–594. doi: 10.1152/jappl.1956.8.6.587.
    1. Kuo CRW, Lipworth B. Airwave oscillometry and patient-reported outcomes in persistent asthma. Ann Allergy Asthma Immunol. 2020;124:289–290. doi: 10.1016/j.anai.2019.12.017.
    1. King GG, Bates J, Berger KI, Calverley P, de Melo PL, Dellacà RL, et al. Technical standards for respiratory oscillometry. Eur Respir J. 2020;27(2):1900753. doi: 10.1183/13993003.00753-2019.
    1. Brashier B, Salvi S. Measuring lung function using sound waves: role of the forced oscillation technique and impulse oscillometry system. Breathe. 2015;11:57–65. doi: 10.1183/20734735.020514.
    1. Coates AL, Graham BL, McFadden RG, McParland C, Moosa D, Provencher S, et al. Spirometry in primary care. Can Respir J. 2013;20:13–22. doi: 10.1155/2013/615281.
    1. Skylogianni E, Douros K, Anthracopoulos MB, Fouzas S. The forced oscillation technique in paediatric respiratory practice. Paediatr Respir Rev. 2016;18:46–51.
    1. Galant SP, Komarow HD, Shin HW, Siddiqui S, Lipworth BJ. The case for impulse oscillometry in the management of asthma in children and adults. Ann Allergy Asthma Immunol. 2017;118:664–671. doi: 10.1016/j.anai.2017.04.009.
    1. Lundblad LKA, Chow C. Lung function monitoring in the era of respiratory pandemics. Clin Physiol Funct Imaging. 2020;40:377–379. doi: 10.1111/cpf.12650.
    1. Chiu HY, Hsiao YH, Su KC, Lee YC, Ko HK, Perng DW. Small airway dysfunction by impulse oscillometry in symptomatic patients with preserved pulmonary function. J Allergy Clin Immunol Pract. 2020;8:229–235. doi: 10.1016/j.jaip.2019.06.035.
    1. Sharshar RS. Impulse oscillometry in small airway dysfunction in asthmatics and its utility in asthma control. Eur Respir J. 2018;13:452–458.
    1. Oostveen E, MacLeod D, Lorino H, Farré R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22:1026–1041. doi: 10.1183/09031936.03.00089403.
    1. Iwatsubo Y, Lorino H, Hubert C, Duvivier C, Peslin R, Pham Q, et al. Measurement of respiratory impedance by forced oscillation: comparison of the standard and head generator methods. Eur Respir J. 1994;7:901–906.
    1. Pasker H, Peeters M, Genet P, Clement J, Nemery B, Van de Woestijne K. Short-term ventilatory effects in workers exposed to fumes containing zinc oxide: comparison of forced oscillation technique with spirometry. Eur Respir J. 1997;10:1523–1529. doi: 10.1183/09031936.97.10071523.
    1. Pairon J, Iwatsubo Y, Hubert C, Lorino H, Nouaigui H, Gharbi R, et al. Measurement of bronchial responsiveness by forced oscillation technique in occupational epidemiology. Eur Respir J. 1994;7:484–489. doi: 10.1183/09031936.94.07030484.
    1. Handa H, Huang J, Murgu SD, Mineshita M, Kurimoto N, Colt HG, et al. Assessment of central airway obstruction using impulse oscillometry before and after interventional bronchoscopy. Respir Care. 2014;59:231–240. doi: 10.4187/respcare.02094.
    1. Yasuo M, Kitaguchi Y, Kosaka YTM, Wada Y, Kinjo T, Ushiki A, et al. Differences between central airway obstruction and chronic obstructive pulmonary disease detected with the forced oscillation technique. Int J COPD. 2020;15:1425. doi: 10.2147/COPD.S246126.
    1. Yasuo M, Kitaguchi Y, Kinota F, Kosaka M, Urushihata K, Ushiki A, et al. Usefulness of the forced oscillation technique in assessing the therapeutic result of tracheobronchial central airway obstruction. Respir Investig. 2018;56:222–229. doi: 10.1016/j.resinv.2018.01.005.
    1. Johnson MK, Birch M, Carter R, Kinsella J, Stevenson RD. Use of reactance to estimate transpulmonary resistance. Eur Respir J. 2005;25:1061–1069. doi: 10.1183/09031936.05.00082504.
    1. Clement J, Landser FJ, Van de Woestijne KP. Total resistance and reactance in patients with respiratory complaints with and without airways obstruction. Chest. 1983;83:215–220. doi: 10.1378/chest.83.2.215.
    1. Van Noord JA, Clement J, Van de Woestijne KP, Demedts M. Total respiratory resistance and reactance in patients with asthma, chronic bronchitis, and emphysema. Am Rev Respir Dis. 1991;143:922–927. doi: 10.1164/ajrccm/143.5_Pt_1.922.
    1. Brown NJ, Xuan W, Salome CM, Berend N, Hunter ML, Musk AW, et al. Reference equations for respiratory system resistance and reactance in adults. Respir Physiol Neurobiol. 2010;172:162–168. doi: 10.1016/j.resp.2010.05.013.
    1. Schulz H, Flexeder C, Behr J, Heier M, Holle R, Huber RM, et al. Reference values of impulse oscillometric lung function indices in adults of advanced age. PLoS ONE. 2013;8:e63366. doi: 10.1371/journal.pone.0063366.
    1. Pakhale S, Tariq S, Huynh N, Jama S, Kaur T, Charron C, et al. Prevalence and burden of obstructive lung disease in the urban poor population of Ottawa, Canada: a community-based mixed-method, observational study. BMC Public Health. 2021;24:1–11.
    1. Pakhale S, Kaur T, Florence K, Rose T, Boyd R, Haddad J, et al. The Ottawa citizen engagement and action model (OCEAM): a citizen engagement strategy operationalized through the participatory research in Ottawa, Management and Point-of-care of Tobacco (PROMPT) Study. Res Involv Engagem. 2016;2:1–18. doi: 10.1186/s40900-016-0034-y.
    1. Pakhale S, Kaur T, Rose T, Florence K, LeBlanc S, Muckle W, et al. The PROMPT study: participatory research in Ottawa: management and point-of-care of tobacco-a community-based participatory action research project. BMJ Open. 2017.
    1. Bourbeau J, Tan WC, Benedetti A, Aaron SD, Chapman KR, Coxson HO, et al. Canadian cohort obstructive lung disease (CanCOLD): fulfilling the need for longitudinal observational studies in COPD. COPD J Chronic Obstr Pulm Dis. 2012;11:125–132. doi: 10.3109/15412555.2012.665520.
    1. Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014;44:873–884. doi: 10.1183/09031936.00025214.
    1. Lundblad LKA, Siddiqui S, Bossé Y, Dandurand RJ. Applications of oscillometry in clinical research and practice. Can J Respir Crit Care Sleep Med. 2019;5:54–68.
    1. Charron CB, Hudani A, Kaur T, Rose T, Florence K, Jama S, et al. Assessing community (peer) researcher’s experiences with conducting spirometry and being engaged in the ‘Participatory Research in Ottawa: Management and Point-of-care for Tobacco-dependence’(PROMPT) project. Res Involv Engagem. 2018;4:1–11. doi: 10.1186/s40900-018-0125-z.
    1. Hankinson J, Odencrantz J, Fedan K. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179–187. doi: 10.1164/ajrccm.159.1.9712108.
    1. Fenton ME, Graham BL, Stanojevic S, Whitford L, Ironstand L. Interpretation of spirometry in Saskatchewan first nations adults. Ann Am Thorac Soc. 2018;15:1237–1239. doi: 10.1513/AnnalsATS.201711-909RL.
    1. Jama S, Pakhalé S. Innovative community based participatory action approach to tackling tobacco health inequities in urban poor populations. Handbook of social inclusion. 2021.
    1. Oostveen E, Boda K, Van Der Grinten CPM, James AL, Young S, Nieland H, et al. Respiratory impedance in healthy subjects: baseline values and bronchodilator response. Eur Respir J. 2013;42:1513–1523. doi: 10.1183/09031936.00126212.
    1. Mauer MP, Cummings KR. Impulse oscillometry and respiratory symptoms in world trade center responders, 6 years post-9/11. Lung. 2010;188:107–113. doi: 10.1007/s00408-009-9206-y.
    1. Hwang SW, Wilkins R, Tjepkema M, O’Campo PJ, Dunn JR. Mortality among residents of shelters, rooming houses, and hotels in Canada: 11 Year follow-up study. BMJ (Online) 2009;339:b4036.
    1. Hwang SW. Homelessness and health. Can Med Assoc J. 2001;164:229–233.
    1. Vijayaraghavan M, Elser H, Frazer K, Lindson N, Apollonio D. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database Syst Rev. 2020;12:CD013413.
    1. Snyder LD, Eisner MD. Obstructive lung disease among the urban homeless. Chest. 2004;125:1719–1725. doi: 10.1378/chest.125.5.1719.
    1. Cottee AM, Seccombe LM, Thamrin C, King GG, Peters MJ, Farah CS. Bronchodilator response assessed by the forced oscillation technique identifies poor asthma control with greater sensitivity than spirometry. Chest. 2020;157:1435–1441. doi: 10.1016/j.chest.2019.12.035.
    1. Crim C, Celli B, Edwards LD, Wouters E, Coxson HO, Tal-Singer R, et al. Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results. Respir Med. 2011;105:1069–1078. doi: 10.1016/j.rmed.2011.01.010.
    1. Crapo RO, Casaburi R, Coates AL, Enright PL, MacIntyre NR, McKay RT, et al. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117. doi: 10.1164/ajrccm.166.1.at1102.
    1. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–46. Erratum in: Eur Respir J. 2006.
    1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2021.

Source: PubMed

3
Se inscrever